Patten & Patten’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Sell |
30,166
-481
| -2% | -$33.2K | 0.13% | 115 |
|
|
2025
Q1 | $2.13M | Buy |
30,647
+8,792
| +40% | +$611K | 0.14% | 108 |
|
|
2024
Q4 | $1.88M | Buy |
21,855
+18,090
| +480% | +$1.56M | 0.12% | 119 |
|
|
2024
Q3 | $448K | Buy |
3,765
+1,720
| +84% | +$205K | 0.03% | 226 |
|
|
2024
Q2 | $292K | Buy |
2,045
+35
| +2% | +$5K | 0.02% | 261 |
|
|
2024
Q1 | $258K | Buy |
+2,010
| New | +$258K | 0.02% | 273 |
|
|
2017
Q2 | – | Sell |
-31,990
| Closed | -$548K | – | 253 |
|
|
2017
Q1 | $548K | Sell |
31,990
-18,350
| -36% | -$314K | 0.06% | 162 |
|
|
2016
Q4 | $903K | Sell |
50,340
-127,770
| -72% | -$2.29M | 0.11% | 121 |
|
|
2016
Q3 | $3.7M | Sell |
178,110
-59,050
| -25% | -$1.23M | 0.48% | 63 |
|
|
2016
Q2 | $6.38M | Buy |
237,160
+5,350
| +2% | +$144K | 0.88% | 39 |
|
|
2016
Q1 | $6.28M | Buy |
231,810
+3,650
| +2% | +$98.9K | 0.9% | 37 |
|
|
2015
Q4 | $6.63M | Buy |
228,160
+14,410
| +7% | +$418K | 0.92% | 36 |
|
|
2015
Q3 | $5.8M | Buy |
213,750
+111,830
| +110% | +$3.03M | 0.88% | 44 |
|
|
2015
Q2 | $2.79M | Buy |
101,920
+18,880
| +23% | +$517K | 0.41% | 73 |
|
|
2015
Q1 | $2.22M | Buy |
83,040
+31,090
| +60% | +$830K | 0.32% | 80 |
|
|
2014
Q4 | $1.1M | Buy |
51,950
+25,470
| +96% | +$539K | 0.17% | 106 |
|
|
2014
Q3 | $630K | Buy |
26,480
+1,000
| +4% | +$23.8K | 0.1% | 135 |
|
|
2014
Q2 | $588K | Sell |
25,480
-250
| -1% | -$5.77K | 0.1% | 136 |
|
|
2014
Q1 | $587K | Buy |
+25,730
| New | +$587K | 0.08% | 173 |
|